4-oxopentanal has been researched along with Psoriasis in 1 studies
*Psoriasis: A common genetically determined, chronic, inflammatory skin disease characterized by rounded erythematous, dry, scaling patches. The lesions have a predilection for nails, scalp, genitalia, extensor surfaces, and the lumbosacral region. Accelerated epidermopoiesis is considered to be the fundamental pathologic feature in psoriasis. [MeSH]
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gęgotek, A; Jastrząb, A; Skrzydlewska, E; Wójcik, P; Wroński, A; Żebrowska, A | 1 |
1 other study(ies) available for 4-oxopentanal and Psoriasis
| Article | Year |
|---|---|
Effect of redox imbalance on protein modifications in lymphocytes of psoriatic patients.
Topics: Adult; Aldehydes; Apoptosis; Arthritis, Psoriatic; Caspase 3; Chromatography, Liquid; Female; Glutathione Peroxidase; Humans; Ketones; Lymphocytes; Male; Malondialdehyde; Middle Aged; NF-E2-Related Factor 2; Oxidation-Reduction; Protein Processing, Post-Translational; Psoriasis; Reactive Oxygen Species; Tandem Mass Spectrometry; Vitamin E Deficiency | 2020 |